Alloy Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-15.
Alloy Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 15, 2026. The filing reports $30.02M sold. Its industry group is Biotechnology. It names Jason Coloma (Director), Errik Anderson (Executive Officer, Director), Logan Snyder (Director) (SEC Form D, April 15, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Alloy Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-15 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Alloy Therapeutics, Inc.
Free to see. No signup.
More on the people and the money behind Alloy Therapeutics, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in April 2026, largest first.
Get an email when Alloy Therapeutics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Alloy Therapeutics, Inc. raises, hires or launches. No email unless you switch it on.
Watch Alloy Therapeutics, Inc. →Get the full cited report on Alloy Therapeutics, Inc.
What the filing shows about Alloy Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alloy Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Alloy Therapeutics, Inc.'s address as 275 Second Ave, Suite 200, Waltham, MA 02451.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Alloy Therapeutics, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Alloy Therapeutics, Inc. See pricing
Alloy Therapeutics, Inc. is a registered filer with the SEC (CIK 1851943) and has filed since 2021-04-02. 3 filings are on record, the latest on 2026-04-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Alloy Therapeutics, Inc.'s Form D of 2026-04-15 names Jason Coloma, Errik Anderson, Logan Snyder and 7 more as its officers, directors or promoters.
Its new offerings report $146.76M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $30.02M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Jason Coloma is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Errik Anderson is named as Executive Officer and Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Logan Snyder is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Ulrik Nielsen is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Jason Camm is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Alex Kolicich is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Piotr Bobrowicz is named as Executive Officer and Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Anthony Sun is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Alaa Halawa is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
Christian Kanady is named as Director on the Form D that Alloy Therapeutics, Inc. filed with the SEC on 15 April 2026, one of 10 people that filing names.
10 people named on the filing — 2 holding an executive role and 8 as directors only.
Named as of the 2026-04-15 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Alloy Therapeutics, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Alloy Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Alloy Therapeutics, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Alloy Therapeutics, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Alloy Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Alloy Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/alloy-therapeutics-inc-form-d-26000001